Filing Details
- Accession Number:
- 0001567619-21-019728
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-10 17:17:02
- Reporting Period:
- 2021-11-08
- Accepted Time:
- 2021-11-10 17:17:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1437402 | Ardelyx Inc. | ARDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611193 | W Jeffrey Jacobs | C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 200 Fremont CA 94555 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-11-08 | 2,166 | $1.18 | 130,237 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021.
- Reflects the adjusted total which includes the purchase of 2,166 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021.
- Reflects the adjusted total which includes the purchase of 2,540 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021.
Billionaire Hedge Funds
